Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

China flag China · Delayed Price · Currency is CNY
22.92
-0.30 (-1.29%)
Jul 30, 2026, 3:00 PM CST
Market Cap3.14B -22.3%
Revenue (ttm)1.34B +1.9%
Net Income152.02M +2.4%
EPS1.12 +2.8%
Shares Out 135.44M
PE Ratio20.73
Forward PEn/a
Dividend0.60 (2.59%)
Ex-Dividend DateJun 5, 2026
Volume864,400
Open23.28
Previous Close23.22
Day's Range22.76 - 23.37
52-Week Range21.90 - 33.30
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China and internationally. The company offers excipients for injection, oral, and topical applications; and active pharmaceutical ingredients (API), such as polidocanol and polyethylene glycol 3350 API/polyethylene glycol 4000 API. It also provides biomaterial products; water-ethylene glycol fire resistant hydraulic fluid, biodegradable hydrau... [Read more]

Sector Healthcare
Founded 2000
Employees 718
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603351
Full Company Profile

Financial Performance

In 2025, SHA:603351's revenue was 1.34 billion, an increase of 2.95% compared to the previous year's 1.30 billion. Earnings were 150.97 million, an increase of 3.11%.

Financial Statements